IAVI and its partners are advancing a diverse porfolio of select preventive HIV vaccine candidates.
IAVI details its organizational strategic vision for the period 2011-2015 made.
Engage with IAVI on your social media networks.
In Memoriam: Dr. Chris Scanlan, our colleague and friend at the Scripps Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, 1977-2013
VOICE Trial Results Underscore Need to Accelerate Development of Additional HIV Prevention Options for Women
AVAC Report Finds That World is Already Falling Behind Pace to End AIDS Epidemic; Five Essential Actions Needed in 2013 to Avoid Historic Missed Opportunity
CAPRISA: Study discovers a unique feature of HIV that enables infected people to make antibodies able to kill a wide range of human immunodeficiency viruses
October 22, 2012
HIV Vaccines and Microbicides Resource Tracking Working Group report calls for sustained funding of HIV prevention research
July 23, 2012
AIDS 2012 Conference Plenary—Ending the Epidemic: Turning the Tide Together
July 23, 2012
NIH Awards $31 Million for HIV/AIDS Vaccine Immunology and Immunogen Discovery
July 11, 2012
Laboratory Studies Provide Possible Explanation for How the RV144 Vaccine Regimen May Have Protected Against HIV
April 4, 2012
GHTC 2012 Policy Report
February 28, 2012
Sign up for our e-mail newsletter.
International AIDS Vaccine Initiative. All rights reserved. International AIDS Vaccine Initiative, IAVI and the IAVI logo are trademarks of the International AIDS Vaccine Initiative, Inc.